ESTRADIOL
- Product NDC
- 51655-860
- Requested package NDC
- 51655-860-52
- 11-digit product format
- 516550860
- Labeler code
- 51655
- Product ID
- 51655-860_4bbc8ae6-5a91-a88b-e063-6294a90a809f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ESTRADIOL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA040275
- Marketing category
- ANDA
- Marketing start
- 2023-02-09
- Substance
- ESTRADIOL
- Active strength
- .5 mg/1
- Pharmacologic classes
- Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040275-001 | ESTRADIOL | ESTRADIOL | 0.5MG | TABLET / ORAL | AB | 1998-12-29 | |
| A040275-002 | ESTRADIOL | ESTRADIOL | 1MG | TABLET / ORAL | AB | 1998-12-29 | |
| A040275-003 | ESTRADIOL | ESTRADIOL | 2MG | TABLET / ORAL | AB | 1998-12-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040275-001 | AB |
| A040275-002 | AB |
| A040275-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040275-001 | ESTRADIOL | 0.5MG | TABLET / ORAL | AB | 1998-12-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040275-002 | ESTRADIOL | 1MG | TABLET / ORAL | AB | 1998-12-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040275-003 | ESTRADIOL | 2MG | TABLET / ORAL | AB | 1998-12-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040275-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040275-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040275-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ESTRADIOL | ESTRADIOL | A-S Medication Solutions | 5c9a2e0f-704b-4d16-8ea3-d94f7f36ce6b | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | REMEDYREPACK INC. | 477cb52e-8ce2-491f-94a0-869ff60bf7ab | 2026-06-08 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | A-S Medication Solutions | afd70875-0a93-40a7-842e-f4359818c2d9 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | REMEDYREPACK INC. | 170ec388-d399-4543-8743-208394b38904 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | Northwind Health Company, LLC | f76aff99-f415-9045-e053-6294a90afd51 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 51655-860-52 51655-860 51655086052 |
| ESTRADIOL | ESTRADIOL | Preferred Pharmaceuticals Inc. | 9956a196-fefd-4766-a225-e154fbd3aeff | 2025-05-01 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | Bryant Ranch Prepack | fad3813c-9495-416b-9789-623d5758b4e3 | 2025-03-28 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | Bryant Ranch Prepack | cf1ebc1d-8f3c-4468-b565-f0da69986e7c | 2025-03-28 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | Bryant Ranch Prepack | bfc1beb9-1ade-446e-97dd-55b41c2fa851 | 2025-03-25 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | A-S Medication Solutions | 8788ddd1-36a6-416a-b527-75eb41de2808 | 2025-02-18 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | Asclemed USA, Inc. | 487ce40e-1f13-4497-994a-c5d91b87b6cc | 2025-02-13 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| Estradiol | ESTRADIOL | Direct_Rx | 032135ee-7bc9-5cdf-e063-6394a90ad9a2 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| Estradiol | ESTRADIOL | Direct_Rx | 01789bad-4be4-ae22-e063-6294a90af392 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | A-S Medication Solutions | 376beb31-5fed-4aae-a16f-71a7d243d5eb | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | PURACAP LABORATORIES, LLC | 97ace322-341a-4d52-8c63-17265ed9aa8d | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | EPIC PHARMA, LLC | 9333d92f-2585-4b99-aaea-87c01c95125e | 2025-01-07 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | NuCare Pharmaceuticals, Inc. | 5423c0da-eb10-20cd-e054-00144ff8d46c | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | NuCare Pharmaceuticals,Inc. | 7093dbe4-b096-2ddb-e053-2991aa0a1bb8 | 2024-06-10 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
| ESTRADIOL | ESTRADIOL | Asclemed USA, Inc. | 229b4ec5-d3c8-4406-9fc5-8f633c6447b8 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | 040275 ANDA040275 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ESTRADIOL
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ESTRADIOL | .5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4TI98Z838E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 197657 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f76aff99-f415-9045-e053-6294a90afd51 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51655-860-26 | 2026-01-29 | C162847 | 48780-1 | 49896155-ccfa-586f-e063-e6dba90add90 | Estradiol Tablets, USP |
| 51655-860-52 | 2026-01-29 | C162847 | 48780-1 | 49896155-ccfa-586f-e063-e6dba90add90 | Estradiol Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51655-860-26 | ESTRADIOL | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 5 | |
| 51655-860-52 | ESTRADIOL | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197657 | estradiol 0.5 MG Oral Tablet | PSN | f76aff99-f415-9045-e053-6294a90afd51 | 5 |
| 197657 | estradiol 0.5 MG Oral Tablet | SCD | f76aff99-f415-9045-e053-6294a90afd51 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 51655-860-52 | 51655086052 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-860-52) | 30 tablet | 2023-02-09 | No | No | Current |